U.S. Construction Stock News

Professional and business services stocks are sitting close to the action as job openings climb to 7.6 million and companies juggle strong labor demand with slower hiring. More roles posted, fewer people hired, and fewer workers quitting create a very specific backdrop for firms that advise, support, and outsource work for employers. With the Federal Reserve expected to keep rates steady, some businesses may lean harder on external service providers instead of adding full time staff. This...

Why Jack Henry & Associates (JKHY) is back on investors’ radar Jack Henry & Associates (JKHY) is in focus after expanding its work with Google Cloud to build an AI-driven security platform for community banks and credit unions, along with new core and digital wins with regional institutions. See our latest analysis for Jack Henry & Associates. Despite the recent AI security announcement with Google Cloud and new core and digital wins with regional banks, Jack Henry & Associates’ share price...

Regulated industries are back in focus as fresh policy shifts, new rules and unsettled market sentiment push investors to rethink where they want exposure. When regulation and economic policy are in motion, large caps with solid health metrics can sometimes offer a steadier way to stay invested, or a reason to step aside. This Regulated Industries Leaders screener filters for bigger Financials and Healthcare stocks that appear well placed against the latest headlines. Below, three stocks that...

New Deckorators Plant Puts UFP Industries Stock in Focus UFP Industries (UFPI) is back on investor radars after subsidiary Deckorators opened a US$77 million manufacturing plant in Lackawanna, New York, doubling production capacity for its Surestone decking products. See our latest analysis for UFP Industries. The new Deckorators plant arrives as UFP Industries shares trade at US$92.07, with a 1 month share price return of 12.98% and a 5 year total shareholder return of 30.97%. Over the past...

Eli Lilly (LLY) is back in focus for investors after its recent share performance, with the stock closing at $1,127.69 and sitting within a large pharmaceutical portfolio that spans cardiometabolic, oncology, immunology, and neuroscience therapies. See our latest analysis for Eli Lilly. The recent 0.93% 1 day share price return has added to Eli Lilly’s strong momentum, with a 30 day share price return of 5.91% and a 1 year total shareholder return of 42.83%. If Eli Lilly’s run has you...

Shareholder Proposal Puts Linde’s Renewable Energy Use in the Spotlight NorthStar Asset Management has filed a shareholder proposal at Linde (NasdaqGS:LIN), asking for a report on the company’s renewable electricity procurement strategy ahead of the July 28, 2026 annual meeting. The request focuses on whether Linde’s board could adopt a clear policy for future renewable power purchases, adding an environmental, social, and governance angle to how some investors may already be thinking about...

Curious whether Spotify Technology is priced fairly today or if the recent volatility has created an opportunity? This article focuses squarely on what the current share price might mean for value conscious investors. At a last close of US$441.21, the stock is down 5.7% over the past week, 16.7% over the past month and 23.3% year to date, although it is still up 177.0% over three years and 64.2% over five years. Recent coverage around Spotify Technology has centered on its role in the...

BioNTech (NasdaqGS:BNTX) shares have recently drawn investor attention after a period marked by mixed returns, including a gain of about 5% over the past 3 months but a decline of roughly 15% over the past year. See our latest analysis for BioNTech. At the current share price of US$90.00, BioNTech’s recent trading has been fairly muted, with the 30 day share price return down 2.44% and the 90 day share price return up 5.04%, while the 5 year total shareholder return is down 59.43%. This...

Recently, Atlassian was named a Leader in Gartner’s inaugural Magic Quadrant for Developer Productivity Insight Platforms, reflecting strong execution and vision among 12 vendors and coinciding with Q3 FY2026 revenue growth of 32% year over year and cloud revenue growth of 29%. The combination of this third-party validation and the Service Collection surpassing US$1.00 billion in annual recurring revenue underscores Atlassian’s push to become a broader workflow and AI-assisted productivity...

Abbott Laboratories (NYSE:ABT) is rolling out its Instinct continuous glucose monitoring sensor across Europe as part of MiniMed insulin pump systems. The integration brings Abbott's CGM technology directly into new automated insulin delivery platforms for diabetes patients. At the same time, Abbott is increasing its presence in emerging markets through biosimilar and branded generic medicine launches and regulatory approvals. For investors watching Abbott Laboratories, these moves connect...

Nokia Oyj (NYSE:NOK) has drawn investor attention after its shares closed at $13.98, with recent returns mixed across different time frames and longer term performance showing very large total return figures. See our latest analysis for Nokia Oyj. Against this backdrop, Nokia Oyj’s recent 1-day and 7-day share price returns of 1.23% and 3.63% come after a 30-day share price decline of 15.07%. Its year to date share price return of 114.75% and very large multi year total shareholder returns...

Celanese (NYSE:CE) has entered a collaboration with Siegwerk to supply bio-based ethyl acetate for more sustainable printing ink solutions. The partnership focuses on offering a drop-in solvent alternative that aims to reduce reliance on fossil-based materials in packaging and printing applications. For investors tracking Celanese, the Siegwerk collaboration highlights how the company is positioning its specialty chemicals portfolio around lower-impact materials. Celanese already operates...

Commercial Metals (CMC) just turned in a busy Q3 2026, with revenue of about US$2.5b and basic EPS of US$1.56, backed by trailing twelve month revenue of roughly US$8.9b and EPS of US$5.35 that frame the latest quarterly run rate. Over the past year, the company has seen revenue move from about US$7.8b on a trailing basis to roughly US$8.9b, while quarterly EPS ranged from US$0.74 in Q3 2025 to US$1.60 in Q1 2026 before landing at US$1.56 this quarter. This gives investors a clearer view of...

Earlier in June 2026, Peabody’s Australian subsidiaries entered into new A$700,000,000 surety bond facilities with Liberty Mutual and Swiss Re, secured against most of their assets and supported by amendments to the group’s revolving credit facility to permit this additional indebtedness and related liens. The move to replace 100% cash‑collateralised reclamation bonds with these facilities could free up liquidity for Peabody’s Australian operations while introducing new covenant and security...

Inflation at 4.1%, shifting expectations for Fed rate moves and volatile energy prices linked to events in Iran are reshaping how investors look at US value stocks. When markets rethink what cash flows are worth under changing interest rate assumptions, some companies can stand out on traditional measures like P/E, P/B and price to cash flow. This article uses a US Value Stocks screener, built around those valuation metrics and balance sheet strength, to spotlight 3 stocks that appear...

Wondering if Morgan Stanley is still worth considering at today's price, or if most of the easy gains are already behind it? This article explains what the current share price could imply about value. The stock recently closed at US$221.04, with returns of 9.6% over the past month, 21.5% year to date, and 62.0% over the last 12 months, while the past week saw a 1.0% decline. Recent coverage of Morgan Stanley has focused on its position within diversified financials and how investors are...

TD SYNNEX (SNX) has just posted Q2 2026 results with revenue of US$19.6 billion and basic EPS of US$4.20, alongside trailing twelve month revenue of US$69.8 billion and EPS of US$14.03 that reflect the impact of the last four quarters. Over the past year, the company has seen revenue move from US$14.9 billion in Q2 2025 to US$19.6 billion in Q2 2026, while quarterly EPS went from US$2.22 to US$4.20, with trailing twelve month EPS stepping up from US$8.61 to US$14.03 over the same period. For...

Asana (NYSE:ASAN) reported that its Asana Gov platform has achieved FedRAMP Moderate Authorization. This certification allows Asana Gov to be used by U.S. federal, state, and local government agencies, contractors, and educational institutions with defined security and compliance needs. The authorization marks an expansion of Asana's addressable market within regulated public sector environments. Asana is best known for its work management and collaboration software, used by teams to...

Sticky inflation, a higher for longer interest rate outlook from the Fed, and energy costs linked to Middle East tensions are reshaping how investors think about banks and insurance stocks. With headline inflation at 4.1% and core inflation at 3.4%, and no clear sign of quick rate relief, the cost of money and risk pricing are front and center again. This article looks at three large, financially healthy Financials stocks from our screener that appear well aligned with this backdrop, and...

Investors may be wondering whether Seagate Technology Holdings still offers value after a strong run, or if the stock is already priced for perfection. At a last close of US$1,025.36, the stock has fallen about 4.2% over the past week, after very large returns over the past year and multi year period, including a 21.2% gain over the last month and a 256.6% return year to date. Recent coverage has focused on Seagate Technology Holdings as a key player in data storage and related technologies,...

Sphere Entertainment (SPHR) drew fresh attention after unveiling plans for a new Sphere Experience featuring The Rocky Horror Picture Show at Sphere, alongside recent analyst commentary and an update on its quarterly profitability. See our latest analysis for Sphere Entertainment. The recent Rocky Horror Sphere Experience announcement and upbeat analyst commentary have arrived alongside strong share price momentum, with a 30-day share price return of 20.28% and a year-to-date share price...

Constellation Energy (NasdaqGS:CEG) has applied for 20-year license renewals for its Ginna and Nine Mile Point Unit 1 nuclear plants in New York. The proposed extensions would allow the reactors to operate until 2049, subject to regulatory approval. The plants are backed by New York's Zero Emissions Credit program, which supports carbon free generation. Constellation Energy is a major US producer of carbon free electricity, and its New York reactors are part of a broader focus on nuclear...

Marqeta (MQ) has become a focus for investors after a recent earnings report in which both revenue and EBITDA came in ahead of analyst forecasts, yet the stock dropped sharply afterward. See our latest analysis for Marqeta. The recent post earnings drop fits into a wider picture where Marqeta’s 1 day share price return of 0.50% and 30 day share price return of 2.86% contrast with a year to date share price decline of 14.87% and a 1 year total shareholder return decline of 32.36%. This...

Erie Indemnity (ERIE) remains in focus for investors after recent trading left the stock with a gain of about 3% over the past month but a decline of roughly 31% over the past year. See our latest analysis for Erie Indemnity. The recent 3.1% 30 day share price return for Erie Indemnity contrasts with a year to date share price decline of 17.2% and a 1 year total shareholder return decline of 31.2%, suggesting momentum has faded even though the 5 year total shareholder return of 30% is still...